Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75
A previously undetected retrovirus has been isolated from the human Epstein–Barr virus (EBV)-negative, B-lymphoblastoid DG-75 cell line, widely used for EBV gene transfection studies. The complete 8207-base genome of the DG-75 retrovirus was molecularly cloned from viral mRNA and sequenced (Accessio...
Saved in:
Published in | Virology (New York, N.Y.) Vol. 308; no. 1; pp. 83 - 91 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
30.03.2003
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A previously undetected retrovirus has been isolated from the human Epstein–Barr virus (EBV)-negative, B-lymphoblastoid DG-75 cell line, widely used for EBV gene transfection studies. The complete 8207-base genome of the DG-75 retrovirus was molecularly cloned from viral mRNA and sequenced (Accession No. AF221065). Northern blot analysis with probes specific for the putative RU-5,
gag, pol, and
env regions identified a full-length viral RNA and spliced
env mRNA. DG-75 viral RNA was isolated from the DG-75 cell sublines UW and KAR, but not from the HAD subline. The DG-75 retrovirus was isolated with primer-binding sites that match tRNA
Thr and tRNA
Gln2. Homology searches revealed homology to (i) xenotropic NZB-9-1
env mRNA, (ii) Moloney-MLV
pol region, and (iii) a truncated
Evi-2 endogenous proviral sequence
gag and
pol region. Viral interference and infectivity assays confirmed the xenotropic nature of the DG-75 retrovirus. The DG-75 retrovirus is the first isolate of an exogenous xenotropic MLV in which the full-length genomic sequence has been characterized. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0042-6822 1096-0341 |
DOI: | 10.1016/S0042-6822(02)00074-0 |